What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 17.84
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 78,049,928 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1.36B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5.12 to US$ 20.33 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -12.04
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 9.23
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 145.24M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -111.4M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
